This inventor holds 1 USPTO granted patent and 10 published patent applications and 1 EPO patent. Top assignee: Biohaven Pharmaceutical Ireland Dac. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Robert Croop - Innovator in CGRP Related Disorders
Introduction
Robert Croop is a notable inventor based in Newton Square, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of CGRP related disorders.
Latest Patents
Robert Croop holds 1 patent for his invention of Rimegepant, a treatment for CGRP related disorders such as migraines. The patent discloses methods of treating these disorders by administering rimegepant or a pharmaceutically acceptable salt thereof. Additionally, it includes pharmaceutical compositions comprising rimegepant and kits that contain these compositions along with instructions for use.
Career Highlights
Croop is currently associated with Biohaven Pharmaceutical Ireland Dac, where he continues to work on innovative solutions in the pharmaceutical industry. His expertise in the field has positioned him as a key player in developing effective treatments for patients suffering from migraines and other related conditions.
Collaborations
Robert Croop collaborates with Vladimir Coric, enhancing the research and development efforts at Biohaven Pharmaceutical Ireland Dac.
Conclusion
Robert Croop's work in developing Rimegepant showcases his commitment to advancing medical treatments for CGRP related disorders. His contributions are vital in improving the quality of life for many patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile